Literature DB >> 12054848

Divergent signaling pathways converge on GATA4 to regulate cardiac hypertrophic gene expression.

Qiangrong Liang, Jeffery D Molkentin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12054848     DOI: 10.1006/jmcc.2002.2011

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


× No keyword cloud information.
  24 in total

1.  Partnering up for cardiac hypertrophy.

Authors:  John P Konhilas; Leslie A Leinwand
Journal:  Circ Res       Date:  2006-04-28       Impact factor: 17.367

2.  ZFP260 is an inducer of cardiac hypertrophy and a nuclear mediator of endothelin-1 signaling.

Authors:  Hiba Komati; Wael Maharsy; Janie Beauregard; Salim Hayek; Mona Nemer
Journal:  J Biol Chem       Date:  2010-11-04       Impact factor: 5.157

3.  Regulation of Ncx1 expression. Identification of regulatory elements mediating cardiac-specific expression and up-regulation.

Authors:  Lin Xu; Ludivine Renaud; Joachim G Müller; Catalin F Baicu; D Dirk Bonnema; Hongming Zhou; Christiana S Kappler; Steven W Kubalak; Michael R Zile; Simon J Conway; Donald R Menick
Journal:  J Biol Chem       Date:  2006-09-10       Impact factor: 5.157

4.  PPARα activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4.

Authors:  Kang Le; Ruifang Li; Suowen Xu; Xiaoqian Wu; Heqing Huang; Yingxia Bao; Yi Cai; Tian Lan; Joel Moss; Cuixian Li; Jian Zou; Xiaoyan Shen; Peiqing Liu
Journal:  Arch Biochem Biophys       Date:  2011-12-16       Impact factor: 4.013

5.  The CRM1 nuclear export receptor controls pathological cardiac gene expression.

Authors:  Brooke C Harrison; Charles R Roberts; David B Hood; Meghan Sweeney; Jody M Gould; Erik W Bush; Timothy A McKinsey
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

6.  Transcription factor GATA4 inhibits doxorubicin-induced autophagy and cardiomyocyte death.

Authors:  Satoru Kobayashi; Paul Volden; Derek Timm; Kai Mao; Xianmin Xu; Qiangrong Liang
Journal:  J Biol Chem       Date:  2009-11-09       Impact factor: 5.157

Review 7.  Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis.

Authors:  P H Sugden; S J Fuller; S C Weiss; A Clerk
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

Review 8.  Calcific Aortic Valve Disease: Part 2-Morphomechanical Abnormalities, Gene Reexpression, and Gender Effects on Ventricular Hypertrophy and Its Reversibility.

Authors:  Ares Pasipoularides
Journal:  J Cardiovasc Transl Res       Date:  2016-05-16       Impact factor: 4.132

9.  Gata4 directs development of cardiac-inducing endoderm from ES cells.

Authors:  Audrey Holtzinger; Gabriel E Rosenfeld; Todd Evans
Journal:  Dev Biol       Date:  2009-10-20       Impact factor: 3.582

10.  Inhibition of cardiomyocyte hypertrophy by protein arginine methyltransferase 5.

Authors:  Ming Chen; Bing Yi; Jianxin Sun
Journal:  J Biol Chem       Date:  2014-07-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.